As of 2025-05-08, the Fair Value of Eastgate Biotech Corp (ETBI) is -0.02 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Eastgate Biotech Corp is -453.33%.
With the market price of 0.00 USD and our fair value calculation, Eastgate Biotech Corp (ETBI) is not a good investment. Investing in ETBI stocks now will result in a potential loss of 453.33%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 5Y Avg | |
| Net income | -0.62 | -1.72 | -4.91 | -4.28 | -2.98 | -2.90 |
| YoY growth | -1,981.62% | -176.21% | -185.28% | 12.76% | 30.45% | -459.98% |
| Market Cap (mil) | 10.16 |
| P/E | |
| Forward P/E |
| EPS | -0.00 |
| Avg earnings growth rate | -459.98% |
| TTM earnings | -7.18 |